Portal de Periódicos da CAPES

Plasmodium falciparum signal peptide peptidase is a promising drug target against blood stage malaria

2009; Elsevier BV; Volume: 380; Issue: 3 Linguagem: Inglês

10.1016/j.bbrc.2009.01.083

1090-2104

Xuerong Li, Huiqing Chen, Noemí Bahamontes‐Rosa, Jürgen F. J. Kun, Boubacar Traoré, Peter D. Crompton, Athar H. Chishti,

Drug Transport and Resistance Mechanisms

The resistance of malaria parasites to current anti-malarial drugs is an issue of major concern globally. Recently we identified a Plasmodium falciparum cell membrane aspartyl protease, which binds to erythrocyte band 3, and is involved in merozoite invasion. Here we report the complete primary structure of P. falciparum signal peptide peptidase (PfSPP), and demonstrate that it is essential for parasite invasion and growth in human erythrocytes. Gene silencing suggests that PfSPP may be essential for parasite survival in human erythrocytes. Remarkably, mammalian signal peptide peptidase inhibitors (Z-LL)2-ketone and L-685,458 effectively inhibited malaria parasite invasion as well as growth in human erythrocytes. In contrast, DAPT, an inhibitor of a related γ-secretase/presenilin-1, was ineffective. Thus, SPP inhibitors specific for PfSPP may function as potent anti-malarial drugs against the blood stage malaria.